MedPath

Investigating the Effectiveness of Combined Treatment of Carboxytherapy with Platelet-Rich Plasma (PRP) Compared To PRP, in Patients with Vitiligo Treated with Phototherapy

Phase 2
Recruiting
Conditions
Vitiligo Disease.
Vitiligo
Registration Number
IRCT20230601058354N1
Lead Sponsor
Kerman University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
30
Inclusion Criteria

A Patient with Vitiligo

Exclusion Criteria

Photosensitive Diseases
Segmental Vitiligo
Patient with positive Kübner's History
Previous History of Keloid Formation
Pregnancy
Breastfeeding
History of Malignant Diseases
Presence of Skin Infection at the Site
Cardiovascular Disease
Acute Embolism
Thrombophlebitis
Kidney Failure
Use of Inhibitor Carbonic Anhydrase (Acetazolamide, Diclofenac),
Systemic Disease
Bleeding disorders or use of Anticoagulant Drugs
Vasovagal Syncope

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Status of Vitiligo Lesions. Timepoint: For all Patients, Light therapy was Performed Three times a week according to the Protocol. It Was Evaluated monthly during the Treatment and 4 Months after the end of the Treatment. Method of measurement: The Diagnosis of the Disease was Made Clinically by a Dermatologist and then confirmed with the help of Wood's Lamp Test.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath